Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.
about
Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Safety assessment of combinati ...... e-topiramate extended release.
@en
type
label
Safety assessment of combinati ...... e-topiramate extended release.
@en
prefLabel
Safety assessment of combinati ...... e-topiramate extended release.
@en
P2860
P1476
Safety assessment of combinati ...... e-topiramate extended release.
@en
P2093
Bruno Halpern
Marcio C Mancini
P2860
P356
10.1080/14740338.2017.1247807
P407
P577
2016-10-12T00:00:00Z